rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2004-1-21
|
pubmed:abstractText |
The aim of this study was to investigate the delivery of Cucurbitacin BE to cervical lymph nodes by peri-cancer submucosal injection of the average diameter 85 nm Cucurbitacin BE polylactic acid nanoparticles (CuBE-PLA-NP).
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
D
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1000-1182
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
477-80
|
pubmed:dateRevised |
2010-4-29
|
pubmed:meshHeading |
pubmed-meshheading:14732987-Animals,
pubmed-meshheading:14732987-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:14732987-Carcinoma, Squamous Cell,
pubmed-meshheading:14732987-Cucurbitacins,
pubmed-meshheading:14732987-Delayed-Action Preparations,
pubmed-meshheading:14732987-Drug Carriers,
pubmed-meshheading:14732987-Drug Delivery Systems,
pubmed-meshheading:14732987-Female,
pubmed-meshheading:14732987-Lactic Acid,
pubmed-meshheading:14732987-Lymph Nodes,
pubmed-meshheading:14732987-Lymphatic Metastasis,
pubmed-meshheading:14732987-Male,
pubmed-meshheading:14732987-Mice,
pubmed-meshheading:14732987-Mouth Neoplasms,
pubmed-meshheading:14732987-Nanotechnology,
pubmed-meshheading:14732987-Neck,
pubmed-meshheading:14732987-Particle Size,
pubmed-meshheading:14732987-Polymers,
pubmed-meshheading:14732987-Triterpenes
|
pubmed:year |
2003
|
pubmed:articleTitle |
[The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer].
|
pubmed:affiliation |
Department of Oral and Maxillofacial Surgery, First Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing 400016, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|